ResearcherSouthern Medical UniversityNo recent work listed
Tiansheng Cao
Matched on ORCID iD 0000-0002-4926-570X; OpenAlex author ID A5018654721. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 3
2021: 1 paper · 2022: 1 paper · 2023: 2 papers
Papers 4
- Bioinformatics-based construction of prognosis-related methylation prediction model for pancreatic cancer patients and its application value. Co-author DOI 10.3389/fphar.2023.1086309↗
- Establishment of a 7-gene prognostic signature based on oxidative stress genes for predicting chemotherapy resistance in pancreatic cancer. Co-author DOI 10.3389/fphar.2023.1091378↗
- A Substance P (SP)/Neurokinin-1 Receptor Axis Promotes Perineural Invasion of Pancreatic Cancer and Is Affected by lncRNA LOC389641. Last author DOI 10.1155/2022/5582811↗
- PADI1 contributes to epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma through activating ERK1/2-p38 signaling pathway Last author DOI 10.21203/rs.3.rs-304683/v1↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Tengfei Ji · 4 shared papers, 2021–2023 · strength 0.96
- Paper Bioinformatics-based construction of prognosis-related methylation prediction model for pancreatic cancer patients and … DOI 10.3389/fphar.2023.1086309↗
- Paper Establishment of a 7-gene prognostic signature based on oxidative stress genes for predicting chemotherapy resistance i… DOI 10.3389/fphar.2023.1091378↗
- Paper A Substance P (SP)/Neurokinin-1 Receptor Axis Promotes Perineural Invasion of Pancreatic Cancer and Is Affected by lncR… DOI 10.1155/2022/5582811↗
- Keqiang Ma · 2 shared papers, 2021–2022 · strength 0.42
- Paper A Substance P (SP)/Neurokinin-1 Receptor Axis Promotes Perineural Invasion of Pancreatic Cancer and Is Affected by lncR… DOI 10.1155/2022/5582811↗
- Paper PADI1 contributes to epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma through activating ERK1/2-p3… DOI 10.21203/rs.3.rs-304683/v1↗
- Shengmin Zhang · 1 shared paper, 2023 · strength 0.24
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.